CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Clinical trial NCT00043420 · COMPLETED

Trial details

NCT number: NCT00043420
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous

Start date: 2003-01-01
Primary completion: 2007-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.